Data / Crowdfunding / Utah / Phoenix PharmaLabs, Inc.
Phoenix PharmaLabs, Inc.: crowdfunding raise on NetCapital Funding Portal Inc., $10,000 to $1,070,000 (2021)
Phoenix PharmaLabs, Inc., a corporation in North Salt Lake, UT, filed a Form C with the SEC on May 10, 2021 to raise $10,000 to $1,070,000 in common stock through NetCapital Funding Portal Inc.. The offering closed on June 18, 2021. In its most recent fiscal year it reported $2,065,804 in revenue and a net loss of $884,105, with 4 employees.
SpecStream is the live web data engine for teams and agents. It reads every Form C on SEC EDGAR each morning, and this page is that reading. Ask for your own cut (a portal, a state, a size, a revenue range) and new raises arrive in your sheet, CRM, Slack or agent as they land.
- Website
- www.phoenixpharmalabs.com
- Funding portal
- NetCapital Funding Portal Inc.
- Address
- 909 N 400 W STE 3, North Salt Lake, UT 84054
- Legal form
- Corporation
- Jurisdiction
- UT
- Incorporated
- January 23, 2002
- SEC CIK
- 0001755778
Offering terms
From the amendment filed May 10, 2021.
- Security
- Common Stock
- Price
- $1.00
- Target
- $10,000
- Maximum
- $1,070,000
- Deadline
- June 18, 2021
- Portal compensation
- Up to 4.9% of amount raised for a successful offering and a listing fee of up to $5,000
Financials
From the Form C-AR filed May 7, 2024.
| Most recent fiscal year | Prior fiscal year | Source | |
|---|---|---|---|
| Revenue | $2,065,804 | $167,209 | sec.gov |
| Cost of goods sold | $0 | $0 | sec.gov |
| Net income | $-884,105 | $-1,015,172 | sec.gov |
| Taxes paid | $0 | $0 | sec.gov |
| Total assets | $796,285 | $307,170 | sec.gov |
| Cash | $796,285 | $307,170 | sec.gov |
| Accounts receivable | $0 | $0 | sec.gov |
| Short-term debt | $0 | $0 | sec.gov |
| Long-term debt | $5,328,028 | $3,358,257 | sec.gov |
Filings
| Filed | Filing | Target | Maximum | Deadline | Note | Source |
|---|---|---|---|---|---|---|
| May 7, 2024 | Annual report | Not listed | Not listed | sec.gov | ||
| August 6, 2021 | Progress update | $10,000 | $1,070,000 | June 18, 2021 | End of offering. Issuer closed its offering with estimated gross proceeds of $1,065,500. The foregoing is in regard only to the amount raised under the Section 4(a)(6) exemption. | sec.gov |
| May 10, 2021 | Amendment | $10,000 | $1,070,000 | June 18, 2021 | the issuer extended the offering date. | sec.gov |
| April 19, 2021 | Amendment | $10,000 | $1,070,000 | May 28, 2021 | issuer extended the offering date. | sec.gov |
| March 22, 2021 | Amendment | $10,000 | $1,070,000 | April 23, 2021 | issuer extended the offering date and updated the financial review with 2020 version. | sec.gov |
| February 10, 2021 | Amendment | $10,000 | $1,070,000 | March 23, 2021 | issuer extended the offering date. | sec.gov |
| January 20, 2021 | Amendment | $10,000 | $1,070,000 | February 22, 2021 | issuer updated their 2019 financial statements. | sec.gov |
| December 18, 2020 | Offering | $10,000 | $1,070,000 | February 22, 2021 | sec.gov | |
| June 12, 2020 | Annual report | Not listed | Not listed | sec.gov | ||
| July 30, 2019 | Progress update | $10,000 | $1,069,999 | March 30, 2019 | End of offering. Issuer closed its offering with estimated gross proceeds of $1,053,330. The foregoing is in regard only to the amount raised under the Section 4(a)(6) exemption. | sec.gov |
| January 29, 2019 | Amendment | $10,000 | $1,069,999 | March 30, 2019 | issuer extended offering deadline. | sec.gov |
| December 20, 2018 | Amendment | $10,000 | $1,069,999 | February 15, 2019 | issuer extended offering deadline. | sec.gov |
| October 23, 2018 | Amendment | $10,000 | $1,069,999 | January 12, 2019 | Fixing typos and adjusting formatting of offering statement. | sec.gov |
| October 12, 2018 | Offering | $10,000 | $1,069,999 | January 12, 2019 | sec.gov |
Updated May 7, 2024. Read from SEC EDGAR. Public domain (U.S. government work). Financials are as each company reported them in its Form C, unaudited unless the filing says otherwise. Websites are the ones the companies declared to the SEC. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.